Rapport Therapeutics: Sofinnova buys 952K shares
The director may be deemed to share voting and dispositive power over entity-held shares, while disclaiming beneficial ownership except to the extent of any pecuniary interest.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Rapport Therapeutics, Inc. (RAPP) director James Healy reported four purchases of common stock on October 28, 2026, made by investment entities: Sofinnova Venture Partners XI, L.P. purchased 952,380 shares; SummitTX Master, SPC – SummitTX Apex SP – Healthcare 3 purchased 6,395; SummitTX Master, SPC – SummitTX Alpha SP – Healthcare 3 purchased 3,772; and SummitTX Pinnacle Master, L.P. – Healthcare 3 purchased 6,933. Each purchase was at $21 per share. The footnotes state that Healy may be deemed to share voting and dispositive power over the entities’ shares, but disclaims beneficial ownership except to the extent of his pecuniary interest, if any. No Rule 10b5-1 plan is reported.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 969,480 shares
Net Buy
4 txns
Insider
HEALY JAMES
Role
Director
Bought
969,480 shs ($20.36M)
Increase in Position
50.9%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 952,380 | $21.00 | $20.00M |
| Purchase | Common Stock F2 | 6,395 | $21.00 | $134K |
| Purchase | Common Stock F3 | 3,772 | $21.00 | $79K |
| Purchase | Common Stock F4 | 6,933 | $21.00 | $146K |
Holdings After Transaction:
Common Stock — 2,815,707 shares (Indirect, By Sofinnova Venture Partners XI, L.P.);
Common Stock — 17,990 shares (Indirect, By SummitTX Master, SPC -SummitTX Apex SP - Healthcare 3);
Common Stock — 14,924 shares (Indirect, By SummitTX Master, SPC - SummitTX Alpha SP - Healthcare 3);
Common Stock — 25,267 shares (Indirect, By SummitTX Pinnacle Master, L.P. - Healthcare 3)
Holdings Before and After:
Common Stock, 1,863,327 to 2,815,707 shares (Indirect, By Sofinnova Venture Partners XI, L.P.);
Common Stock, 11,595 to 17,990 shares (Indirect, By SummitTX Master, SPC -SummitTX Apex SP - Healthcare 3);
Common Stock, 11,152 to 14,924 shares (Indirect, By SummitTX Master, SPC - SummitTX Alpha SP - Healthcare 3);
Common Stock, 18,334 to 25,267 shares (Indirect, By SummitTX Pinnacle Master, L.P. - Healthcare 3)
Other Insiders: 6 other insiders reported open-market purchases of this stock in the 30 days up to this filing.
Footnotes (4)
- F1. The shares are directly held by Sofinnova Venture Partners XI, L.P. ("SVP XI"). Sofinnova Management XI, L.P. ("SM XI LP") is the general partner of SVP XI and Sofinnova Management XI, L.L.C. ("SM XI") is the general partner of SM XI LP. The Reporting Person is a managing member of SM XI and may be deemed to share voting and dispositive power over the shares held by SVP XI. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- F2. The shares are directly held by SummitTX Master, SPC - SummitTX Apex SP - Healthcare 3 (f/k/a Crestline Summit Master, SPC - Crestline Summit Apex SP) ("Apex SP"). Sofinnova BioEquities GP LLC ("BioEquities GP") is the general partner of Apex SP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Apex SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- F3. The shares are directly held by SummitTX Master, SPC - SummitTX Alpha SP - Healthcare 3 (f/k/a Crestline Summit Master, SPC - PEAK SP) ("Alpha SP"). BioEquities GP is the general partner of Alpha SP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Alpha SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- F4. The shares are directly held by SummitTX Pinnacle Master, L.P. - Healthcare 3 (f/k/a Crestline Summit Pinnacle Master, L.P.) ("Pinnacle LP"). BioEquities GP is the general partner of Pinnacle LP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Pinnacle LP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Key Figures
Sofinnova Venture Partners XI, L.P. purchase: 952,380 shares purchased; 2,815,707 shares following transaction
SummitTX Apex SP – Healthcare 3 purchase: 6,395 shares purchased; 17,990 shares following transaction
SummitTX Alpha SP – Healthcare 3 purchase: 3,772 shares purchased; 14,924 shares following transaction
+2 more
5 metrics
Sofinnova Venture Partners XI, L.P. purchase
952,380 shares purchased; 2,815,707 shares following transaction
October 28, 2026
SummitTX Apex SP – Healthcare 3 purchase
6,395 shares purchased; 17,990 shares following transaction
October 28, 2026
SummitTX Alpha SP – Healthcare 3 purchase
3,772 shares purchased; 14,924 shares following transaction
October 28, 2026
SummitTX Pinnacle Master, L.P. – Healthcare 3 purchase
6,933 shares purchased; 25,267 shares following transaction
October 28, 2026
Purchase price per share
$21 per share
All four purchases on October 28, 2026
Key Terms
beneficial ownership, voting and dispositive power, pecuniary interest, Section 16 of the Exchange Act
4 terms
beneficial ownership regulatory
"disclaims beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
voting and dispositive power regulatory
"share voting and dispositive power over the shares"
pecuniary interest regulatory
"extent of his pecuniary interest therein"
Section 16 of the Exchange Act regulatory
"for purposes of Section 16 of the Exchange Act"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What holdings were reported after the RAPP purchases linked to James Healy?
After the reported transactions, Sofinnova Venture Partners XI, L.P. held 2,815,707 shares; SummitTX Master, SPC – SummitTX Apex SP – Healthcare 3 held 17,990; SummitTX Master, SPC – SummitTX Alpha SP – Healthcare 3 held 14,924; and SummitTX Pinnacle Master, L.P. – Healthcare 3 held 25,267.
AI-generated analysis. How Rhea-AI works. Not financial advice.
